HOLLISTON, Mass.--(BUSINESS WIRE)--David Green, CEO of Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, was interviewed by health reporter Dr. Mallika Marshall in a segment during the evening news on the CBS-TV affiliate in Boston (WBZ-TV).
Help employers find you! Check out all the jobs and post your resume.
